Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey L Greene

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Cancers|October 14, 2023
Glucocorticoid Receptor Activation in Lobular Breast Cancer Is Associated with Reduced Cell Proliferation and Promotion of MetastasesBaylee A Porter, Candace Frerich, Muriel Lainé, et al.
Molecular Cancer Research : MCR|May 22, 2021
Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast CancerChristopher G Mayne, Weiyi Toy, Kathryn E Carlson, et al.
Nature Structural Biology|April 16, 2002
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonismAndrew K Shiau, Danielle Barstad, James T Radek, et al.
Biophysical Journal|July 2, 2022
Labeling of a mutant estrogen receptor with an Affimer in a breast cancer cell linePin Ren, Christian Tiede, Sean W Fanning, et al.
Elife|April 13, 2013
Overcoming mutation-based resistance to antiandrogens with rational drug designMinna D Balbas, Michael J Evans, David J Hosfield, et al.
Gynecologic Oncology|October 15, 2011
The effects of 17β-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesisIris L Romero, WooSeok Lee, Anirban K Mitra, et al.
Journal of Medicinal Chemistry|January 19, 2007
Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chainsHai-Bing Zhou, Shubin Sheng, Dennis R Compton, et al.
Cancers|May 28, 2022
Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer CellsPurab Pal, Alec Millner, Svetlana E Semina, et al.
Chemistry & Biology|June 23, 2007
Elemental isomerism: a boron-nitrogen surrogate for a carbon-carbon double bond increases the chemical diversity of estrogen receptor ligandsHai-Bing Zhou, Kendall W Nettles, John B Bruning, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 21, 2017
Metabolism of megestrol acetate in vitro and the role of oxidative metabolitesLarry House, Michael J Seminerio, Snezana Mirkov, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Cancers|October 14, 2023
Glucocorticoid Receptor Activation in Lobular Breast Cancer Is Associated with Reduced Cell Proliferation and Promotion of MetastasesBaylee A Porter, Candace Frerich, Muriel Lainé, et al.
Molecular Cancer Research : MCR|May 22, 2021
Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast CancerChristopher G Mayne, Weiyi Toy, Kathryn E Carlson, et al.
Nature Structural Biology|April 16, 2002
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonismAndrew K Shiau, Danielle Barstad, James T Radek, et al.
Biophysical Journal|July 2, 2022
Labeling of a mutant estrogen receptor with an Affimer in a breast cancer cell linePin Ren, Christian Tiede, Sean W Fanning, et al.
Elife|April 13, 2013
Overcoming mutation-based resistance to antiandrogens with rational drug designMinna D Balbas, Michael J Evans, David J Hosfield, et al.
Gynecologic Oncology|October 15, 2011
The effects of 17β-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesisIris L Romero, WooSeok Lee, Anirban K Mitra, et al.
Journal of Medicinal Chemistry|January 19, 2007
Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chainsHai-Bing Zhou, Shubin Sheng, Dennis R Compton, et al.
Cancers|May 28, 2022
Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer CellsPurab Pal, Alec Millner, Svetlana E Semina, et al.
Chemistry & Biology|June 23, 2007
Elemental isomerism: a boron-nitrogen surrogate for a carbon-carbon double bond increases the chemical diversity of estrogen receptor ligandsHai-Bing Zhou, Kendall W Nettles, John B Bruning, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 21, 2017
Metabolism of megestrol acetate in vitro and the role of oxidative metabolitesLarry House, Michael J Seminerio, Snezana Mirkov, et al.
Pageof 8